Skip to content
  • Tuesday, 27 October 2026
  • 9:35 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • MSD Strengthens Oncology Pipeline with Multi-Billion-Dollar Licensing Deal for Shanghai-Based SciBrunch Therapeutics KRAS Inhibitor SPR2015
Pharmaceutical R&D

MSD Strengthens Oncology Pipeline with Multi-Billion-Dollar Licensing Deal for Shanghai-Based SciBrunch Therapeutics KRAS Inhibitor SPR2015

Teuku Ryan Sep 30, 2026 0

In a strategic move to fortify its oncology portfolio against looming patent expirations, MSD—known as Merck & Co. in the…

Read More
Pharmaceutical R&D

Enveda Biosciences Secures $311m in Series E Funding to Accelerate AI-Powered Natural Drug Discovery Pipeline

Teuku Ryan Sep 28, 2026 0

Colorado-based biotechnology pioneer Enveda Biosciences has officially closed a substantial $311m Series E financing round, bringing its cumulative venture backing…

Read More
Pharmaceutical R&D

Novo Secures $1.4bn Partnership With Orbis Medicines to Bolster Cardiometabolic Pipeline Through AI-Driven Macrocycle Therapeutics

Teuku Ryan Sep 18, 2026 0

In a strategic move to fortify its cardiovascular and metabolic disease pipeline following a sequence of high-profile clinical and commercial…

Read More
Data Science & Bioinformatics

Bridging Traditional Machine Learning and Generative AI: A Comprehensive Guide to Scikit-LLM Estimators and Pipeline Integration

Evan Lee Salim Sep 17, 2026 0

The intersection of classical machine learning and modern generative artificial intelligence has long presented data scientists with a persistent architectural…

Read More
Pharmaceutical R&D

Encoded Therapeutics Secures $275M in Series F Financing to Advance Groundbreaking Gene Therapy for Dravet Syndrome and Expand Clinical Pipeline

Teuku Ryan Sep 10, 2026 0

Encoded Therapeutics has officially closed a massive $275 million Series F financing round, marking a critical financial milestone for the…

Read More
Pharmaceutical R&D

The Adult Epilepsy Market Poised for Substantial Growth Amidst Unmet Clinical Needs and Promising Pipeline Innovations

Teuku Ryan Jul 24, 2026 0

The adult epilepsy market across the seven major markets (7MM: the US, France, Germany, Italy, Spain, the UK, and Japan)…

Read More
Data Science & Bioinformatics

Agentic Workflows to Automate Your Data Science Pipeline

Evan Lee Salim Jul 4, 2026 0

The modern data science landscape is undergoing a significant transformation, driven by the imperative to increase efficiency and strategic impact.…

Read More
Pharmaceutical R&D

Ipsen Acquires Rare Disease Specialist Memo Therapeutics for up to €700 Million, Bolstering Pipeline with Promising BK Polyomavirus Asset

Teuku Ryan Jul 3, 2026 0

Paris, France – In a significant strategic move to expand its rare disease portfolio, global biopharmaceutical company Ipsen announced today…

Read More
Pharmaceutical R&D

Bocunebart’s PACAP-Targeting Mechanism Positions it as a Potential First-in-Class Therapy in a Thin Pipeline of Novel Late-Stage Candidates

Teuku Ryan Jul 2, 2026 0

New Data Unveiled for Bocunebart, a Promising Migraine Preventive Targeting a Novel Pathway Munich, Germany – June 29, 2026 –…

Read More
Data Science & Bioinformatics

Agentic Workflows to Automate Your Data Science Pipeline

Evan Lee Salim Jun 27, 2026 0

The modern data science landscape is increasingly characterized by complexity and scale, yet a significant portion of a data scientist’s…

Read More

Posts pagination

1 2 … 4
TWiV 1293: The enemy of your parasite is your friendNavigating the Evolving Landscape of Oral Solid Dosage Development: A Framework for Enhanced Efficiency and Commercial SuccessHow to tackle the unique pharmacokinetic properties of covalent drugsCPHI 2026 Preview: Pharma Manufacturing Puts AI to Work
The Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals PlummetJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactEliquis Loss of Exclusivity: A Pharmaceutical Patent Cliff of Historic ProportionsMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric Growth
Merck and Moderna’s cancer vaccine is customized for each patient’s tumorAn Unbiased Look at Google Gemini Omni: Features, Costs, and Market ComparisonESMO 2026: Sacituzumab Tirumotecan Sets New Survival Benchmark in Recurrent Endometrial CancerLight-Driven Magnetism Breakthrough Promises Ultrafast, High-Density Digital Data Storage
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Merck and Moderna’s cancer vaccine is customized for each patient’s tumor
Lana Keisha Oct 27, 2026
Data Science & Bioinformatics
An Unbiased Look at Google Gemini Omni: Features, Costs, and Market Comparison
Evan Lee Salim Oct 27, 2026
Pharmaceutical R&D
ESMO 2026: Sacituzumab Tirumotecan Sets New Survival Benchmark in Recurrent Endometrial Cancer
Teuku Ryan Oct 27, 2026
Advanced Materials Science
Light-Driven Magnetism Breakthrough Promises Ultrafast, High-Density Digital Data Storage
Nila Kartika Wati Oct 27, 2026

Copyright © 2026 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ